Clinical Trial Update: The Effect of n-3 LCPUFA on Immune Function and Cardiovascular Risk Factors [NA]

View source ↗

Summary

This clinical trial update reports on the study of omega-3 long-chain polyunsaturated fatty acids (n-3 LCPUFA) and their effects on immune function and cardiova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Metabolic Syndrome

Drugs mentioned

• Omega-3 long-chain polyunsaturated fatty acids (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA))

Snippet

Sponsor: University of Copenhagen | Conditions: Cardiovascular Heart Disease, Metabolic Syndrome | NA | Status: UNKNOWN